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Abstract
Cerium (Ce) is becoming a popular metal for use in electrochemical applications. When in the 
form of cerium oxide (CeO2), Ce can exist in both 3 + and 4 + valence states, acting as an ideal 
catalyst. Previous in vitro and in vivo evidence have demonstrated that CeO2 has either anti- or 
pro-oxidant properties, possibly due to the ability of the nanoparticles to transition between 
valence states. Therefore, we chose to chemically modify the nanoparticles to shift the valence 
state toward 3+. During the hydrothermal synthesis process, 10 mol% gadolinium (Gd) and 20 mol
% Gd, were substituted into the lattice of the CeO2 nanoparticles forming a perfect solid solution 
with various A-site valence states. These two Gd-doped CeO2 nanoparticles were compared to 
pure CeO2 nanoparticles. Preliminary characteristics indicated that doping results in minimal size 
and zeta potential changes but alters valence state. Following characterization, male Sprague-
Dawley rats were exposed to 0.5 or 1.0 mg/kg nanoparticles via a single intratracheal instillation. 
Animals were sacrificed and bronchoalveolar lavage fluid and various tissues were collected to 
determine the effect of valence state and oxygen vacancies on toxicity 1-, 7-, or 84-day post-
exposure. Results indicate that damage, as measured by elevations in lactate dehydrogenase, 
occurred within 1-day post-exposure and was sustained 7-day post-exposure, but subsided to 
control levels 84-day post-exposure. Furthermore, no inflammatory signaling or lipid peroxidation 
occurred following exposure with any of the nanoparticles. Our results implicate that valence state 
has a minimal effect on CeO2 nanoparticle toxicity in vivo.
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Introduction
Ce, the most abundant rare earth metal and a member of the lanthanide series, has been 
implicated in Ce pneumoconiosis, a restrictive lung disease characterized by severe 
pulmonary fibrosis and emphysema (Pairon et al., 1995; Vocaturo et al., 1983). Ce-
containing rare earth metal dusts, which are used in industry for glass polishing and 
photoengraving, have also been associated with severe pulmonary fibrosis and extensive Ce 
particle accumulation in the lungs of industry workers (Pairon et al., 1994). One study 
presented data that Ce can remain within workers’ lungs for more than 20 years (Pairon et 
al., 1994). Thus, the production of new materials containing Ce, such as cerium oxide 
(CeO2) nanoparticles, necessitates toxicity studies to evaluate potential worker exposure 
risks. To date, the literature on CeO2 nanoparticle toxicity is conflicted. Due to the variety of 
uses for CeO2 nanoparticles, including use in electrochemical sensors, fuel cells, and 
reforming catalysts as well as use as a diesel fuel additive to reduce emissions and increase 
engine efficiency (Cassee et al., 2011), toxicity screenings of this nanomaterial and 
determination of CeO2 pulmonary effects is essential.
Previous in vitro studies of the toxicity of CeO2 nanoparticles have shown conflicting 
toxicity results. For example, studies completed in immune cells have reported that CeO2 
protects against induced apoptosis in human lymphocytes (Celardo et al., 2011) or acts as an 
antioxidant under conditions of induced oxidative stress in mouse monocyte macrophage 
cells (Xia et al., 2008). Further, studies conducted in colon cells showed CeO2 nanoparticles 
were capable of preventing radiation-induced damage through antioxidant-like properties 
(Colon et al., 2010). Conversely, studies in various epithelial cell lines indicated that CeO2 
either exerts toxicity through reactive oxygen species (ROS) production (Eom & Choi, 2009; 
Lin et al., 2006; Park et al., 2008) or elicits only mild ROS and has antioxidant-like 
properties (Xia et al., 2008). These results imply that CeO2 toxicity varies between cell type 
and within similar cell types.
The conflicting in vitro data are theorized to be a result of the ability of Ce to readily 
transition between 3+ and 4+ valence states (Das et al., 2007). When Ce is in the 3+ valence 
state, it is hypothesized that it exerts antioxidant potential, while in the 4+ valence state it 
produces free radicals and causes oxidative damage (Celardo et al., 2011; Das et al., 2007; 
Park et al., 2008). To assess the importance of valence state and concentration of oxygen 
vacancies within the material in influencing CeO2 reactivity and toxicity, a technique known 
as doping was employed to modulate the electrical properties of the nanoparticles and force 
them toward a greater 3+ /4+ ratio by incorporating gadolinium (III) oxide (Gd2O3) into the 
nanoparticles (Wang et al., 2011). Two different samples of CeO2 nanoparticles were doped 
and used in this study: a 10 mol% and 20 mol% Gd in CeO2. Pure, unaltered CeO2 
nanoparticles were also tested in addition to a Gd2O3 nanoparticle control to ensure any 
effects seen between compounds were due to valence state and oxygen vacancies rather than 
the presence of Gd2O3, which is known to induce acute lung toxicity (Yoneda et al., 1995). 
Initial in vitro tests by our group determined that as particle doping increased, the 
antioxidant potential of CeO2 nanoparticles decreased in both RLE-6TN alveolar epithelial 
and NR8383 alveolar macrophage rat cells (Dunnick et al., 2015). Others have also shown 
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that valence state had no effect on in vitro toxicity, but as the 3+ / 4+ ratio decreased, the 
antioxidant potential of the nanoparticles also decreased (Celardo et al., 2011).
In vivo studies have shown that CeO2 nanoparticles cause substantial pulmonary damage, 
induce inflammation, and induce fibrosis at a range of doses using a variety of exposure 
methods, including intratracheal (IT) instillation and inhalation (Demokritou et al., 2013; 
Ma et al., 2012). Ma et al. (2011) have shown that at doses ranging from 0.15 mg/kg to 7 
mg/kg, rats presented with markers of fibrosis within 28-day post-IT exposure. A study in 
which rats were exposed to CeO2 nanoparticles via mouth/nose inhalation showed similar 
toxicity results and inflammatory cytokine activation, but also demonstrated significant 
increases in ROS production and disruptions in antioxidant systems (Srinivas et al., 2011). 
Aalapati et al. (2014)
 also presented data that following inhalation studies in mice, CeO2 
nanoparticles induced oxidative stress as measured by induction of lipid peroxidation (LPO) 
and decreased glutathione. This change in ROS was not detected in comparable in vivo 
studies (Demokritou et al., 2013). In addition, studies have also shown that surface coatings 
influence the relative toxicity of CeO2 nanoparticles. For example, when CeO2 nanoparticles 
were coated with amorphous silica, researchers recorded decreased CeO2 induced 
inflammation and fibrosis (Ma et al., 2015). Thus, it may be possible that alterations of the 
physical properties of the CeO2 nanoparticles may decrease their relative reactivity and 
overall toxicity.
While previous studies have been conducted to determine the toxicity of CeO2 nanoparticles 
following deposition in the lungs of rats, this is the first study to assess in vivo changes in 
reactivity and toxicity following chemical alteration to the nanoparticles in a way that affects 
valence state. The aim of this study was to determine the effect of valence state and oxygen 
vacancies on CeO2 reactivity in vivo in order to possibly explain discrepancies among 
studies while addressing the possible cause for these differences. To accomplish this, 
Sprague-Dawley rats were exposed intratracheally to pure CeO2, CeO2 with 10 mol% Gd, or 
CeO2 with 20 mol% Gd nanoparticles. Rats were sacrificed 1-, 7-, or 84-day post-one time 
nanoparticle exposure and overall pulmonary toxicity, ROS, inflammation, and pulmonary 
changes were assessed to address the hypothesis that valence state affects CeO2 in vivo 
toxicity.
Materials and methods
CeO2 nanoparticle production and characterization
Gd-doped CeO2 nanopowder was prepared as previously described (Dunnick et al., 2015). 
Briefly, a hydrothermal method was used in which cerium (IV) ammonium nitrate and 
gadolinium nitrate hexahydrate were dissolved in deionized water and mixed together. 
Tetramethyl ammonium hydroxide was added to the mixture until the pH reached 10, 
followed by precipitate formation. The precipitate was washed and hydrothermally treated at 
240 °C for 1 h to obtain the final nanoparticles.
X-ray photoelectron spectroscopy (XPS) was utilized to determine the changes in valence 
state between samples as previously described (Dunnick et al., 2015). To determine the 
relative size of the nanoparticles in phosphate-buffered saline (PBS), dynamic light 
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scattering (DLS) was performed using a Nano ZS90 instrument (Malvern Instruments, 
Worcestershire, UK). Prior to sample measurement, sample cells were cleaned, rinsed, and 
pre-wetted with filtered PBS. Samples were exposed to ultrasonic agitation for 10 min using 
a probe tip to produce a uniform dispersion.
To determine the relative dispersion stability of the nanomaterials, zeta potential of CeO2, 
and Gd-doped CeO2 nanoparticles in PBS were performed using a Nano ZS90 instrument 
(Malvern Instruments). The viscosity of the PBS was determined at room temperature using 
a VS-10 viscometer (Malvern Instruments) for use in determining zeta potential. Each 
nanoparticle suspension was sonicated for 10 min using a probe tip to produce a uniform 
dispersion. The Smoluchowski approximation of 1.5 was used for Henry’s function and a 
pH of 7.5 was determined for the PBS.
Animal exposures
Male Sprague-Dawley (Hla: SD-CVF) rats (6 weeks old) were purchased from Hilltop 
Laboratories (Scottdale, PA) and pair housed in an animal facility accredited by the 
American Association for Assessment and Accreditation of Laboratory Animal Care in pairs 
in cages individually ventilated cages with HEPA-filtered air. All animals were exposed and 
euthanized according to a National Occupational Institute for Occupational Safety and 
Health approved protocol that complied with the Guidelines for the Care and Use of 
Laboratory Animals. Following a one-week acclimation period, rats were anesthetized with 
40 mg/kg sodium methohexital (Brevital, Eli Lily and Co., Indianapolis IN), weighed, and 
placed on an inclined restraint board. All CeO2 nanoparticle samples were exposed to 
ultrasonic agitation for 5 min prior to animal exposure. Nanoparticles were administered via 
IT at a final concentration of 0.5 mg/kg BW or 1.0 mg/kg BW. PBS was used as a negative 
control. A minimum of 6 rats were treated per group, for each time point and dose, and 
sacrificed at 1-, 7-, or 84-day post-exposure. Since CeO2 nanoparticle exposure does not 
have a set permissible exposure limit (PEL), animal dosages were selected based on previous 
studies (Ma et al., 2012).
Bronchoalveolar lavage
At 1-, 7-, and 84-day post-exposure, bronchoalveolar lavage (BAL) was performed on the 
entire lung to assess lung injury and inflammation (n = 6–7/treatment group). Animals were 
euthanized with sodium pentobarbital (>100 mg/kg) and exsanguinated by cutting the 
abdominal aorta. The lungs were lavaged with 6 ml Ca2+, Mg2+ -free PBS, pH 7.4 to collect 
the first lavage, followed by 8 ml aliquots of PBS until 40 ml were collected for the second 
lavage. Lavage fluid centrifuged at 3000 × g for 10 min at 4 °C. Cell-free supernatants from 
the first lavage were collected for lactate dehydrogenase (LDH) and cytokine analysis. Cell 
pellets were then re-suspended in 1 ml PBS and evaluated as described below. The first 
lavage was used for all cellular experiments except chemiluminescence (CL) and electron 
paramagnetic resonance (EPR) studies, in which cells collected in the second lavage were 
used.
Dunnick et al. Page 4
Nanotoxicology. Author manuscript; available in PMC 2017 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Cellular evaluation and lactate dehydrogenase measurement
Total cell numbers were determined using a Beckman Coulter Multisizer 4 Analyzer 
(Beckman Coulter, Indianapolis, IN). Polymorphonuclear leukocytes (PMN) and alveolar 
macrophages (AM) counts were also determined. Cells were differentiated using a Cytospin 
4 centrifuge (Shandon Life Sciences International, Cheshire, England). Briefly, cell 
suspensions (2 × 105) were spun for 5 min at 72 × g and pelleted onto a slide. Two hundred 
cells/rat were then counted following staining with modified Wright-Giemsa stain and the 
relative abundance of lung AMs, PMNs, lymphocytes, and eosinophils were determined.
Acellular LDH activity from BAL was measured to determine general cell damage and 
toxicity using a COBAS C111 analyzer (Roche Diagnostic Systems, Montclair, NJ).
Chemiluminescence and electron paramagnetic resonance
Luminol-dependent CL was completed to measure macrophage activity and was monitored 
using a Berthold LB953 Luminometer (Berthold, Wildbad, Germany). BAL cell (1 × 106 
AM/ml) luminescence was measured before and after zymosan stimulation (2 mg/ml; Sigma 
Chemical Company, St Louis, MO). Zymosan was used for its ability to stimulate and be 
readily engulfed by activated phagocytic cells (Gantner et al., 2003). Results are presented 
as zymosan-stimulated minus unstimulated cell CL production.
A 5,5′-dimethylpryrroline N-oxide (DMPO) spin trap technique was implemented to form 
long-lived free radicals that could be detected via EPR to assess the reactivity of the cells. 
EPR measurements were collected using a flat cell assembly and Bruker EMX spectrometer 
(Billerica, MA). Second BAL cells (1 × 106 AM/ml) were combined with 200 mM DMPO 
(Sigma Aldrich), and 2 mM Cr (VI) for 3 min at 37 °C prior to hydroxyl radical 
measurement. Instrument settings are indicated in the figure legend. Signal intensity (peak 
height) was used to measure the relative amount of superoxide radicals produced and is 
measured in millimeters. All data are presented as peak height fold change above control 
animal AM response to Cr (VI).
Lipid peroxidation measurements
Following lavage, a segment of the right lung was removed from each animal and 
immediately placed in −80 °C. LPO values, specifically malondialdehyde (MDA) levels, 
were determined according to the manufacturer’s protocol (OxisResearch, Beverly Hills, 
CA) and samples were run in duplicate. Lung tissue was combined with ice-cold PBS (100 
mg/ml) and butylated hydroxytoluene (50 mM) and homogenized for 30 s. Following 
homogenization, samples were centrifuged at 2500 ×g for 10 min at 4 °C. Two hundred 
microliters of clear supernatant was removed and placed in a clean glass tube. After addition 
of kit-specific reagents and incubation at 45 °C for 1 h, samples were centrifuged at 2500 ×g 
for 10 min at room temperature and a clear supernatant was collected and transferred to a 
glass plate. Absorbance was measured at 586 nm.
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Protein analysis
Production of the cytokines TNF-α, IL-8, and IL-6 were determined from first lavage BAL 
using enzyme-linked immunosorbent assays (ELISAs) according to the manufacturers 
protocol (Life Technologies, Grand Island, NY) and samples were run in duplicate.
Histopathological examination
Histopathological examination was performed on lung liver, and kidney sections from a 
separate group of 84-day post-CeO2 nanoparticle or PBS exposed animals, not previously 
lavaged, using hematoxylin–eosin (H&E) staining on formalin-fixed tissues. Lungs were 
fixed via tracheal intubation. Following fixation of tissues in 10% buffered formalin, tissues 
were embedded in paraffin wax, sectioned at 5 µm, mounted on glass slides, and stained. 
Sections were examined by light microscopy by a board-certified pathologist.
Statistical analysis
Data are represented as the mean ± standard error of the mean (SEM) for each condition. To 
compare responses, one-way and two-way analysis of variance (ANOVA) and Tukey post-
test were performed using GraphPad Prism 6 software (GraphPad Software Inc., La Jolla, 
CA). Statistical significance is shown between treatment groups when p < 0.05.
Results
CeO2 nanoparticle characteristics
To determine the relative size of the nanoparticles in PBS, DLS was utilized and showed that 
all of the nanoparticles agglomerated into micron-sized particles (Table 1). Data indicate that 
pure CeO2 nanoparticles agglomerate less than both doped samples (1166 nm pure CeO2 vs. 
2078 nm CeO2 10% Gd vs. 2436 nm CeO2 20% Gd). All nanoparticles had a similar 
spherical morphology. Previous transmission electron microscopy data showed that these 
particles were approximately 5 nm as-prepared prior to suspension (Dunnick et al., 2015), 
but quickly agglomerate due to their high surface energy. Zeta potential results also show a 
similar trend between the nanoparticle samples, as the values fall within the Riddick 
category of delicate dispersion (Riddick, 1968).
Effect of CeO2 nanoparticles on pulmonary toxicity and BAL cells
A number of parameters were evaluated from BAL samples to determine the relative toxicity 
of the nanoparticles. LDH levels were measured to determine the general toxic effects of 
CeO2 nanoparticle exposure. LDH data show that cell membrane damage peaked at 7-day 
post-exposure and returned to baseline LDH levels by 84 days following exposure to CeO2 
and CeO2 10% Gd. However, CeO2 20% Gd exposure resulted in persistently elevated LDH 
levels compared to vehicle control animals 84-day post-exposure (Figure 1A). By 7-day 
post-nanoparticle exposure, total cells counted in BAL were elevated with all nanoparticle 
exposure groups compared to vehicle control animals (Figure 1B). This significant increase 
was also reflected in PMN counts. Conversely, only the 0.5 mg/kg dose of CeO2 and CeO2 
10% Gd and both doses of CeO2 20% Gd induced significant macrophage influx in BAL 
(Figure 1C). By 84-day post-exposure, all cell counts returned to normal compared to 
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vehicle control animals with the exception of the high dose of CeO2 20% Gd, which 
remained elevated (Figure 1B and D).
Cell differentials showed a similar change in pulmonary cellular composition followed by 
recovery over the 84-day experiment. BAL composition changed from mainly macrophages 
in control animals to greater than 50% PMNs following exposure to both pure CeO2 
nanoparticles and CeO2 10% Gd at both doses 1-day post-exposure (Figure 2A). CeO2 20% 
Gd exposure also significantly altered the ratio of macrophages to PMNs relative to PBS 
controltreated animals. However, the effect was less severe at this timepoint compared to 
pure CeO2 and CeO2 10% Gd exposed animals. Pure CeO2 nanoparticles had a significantly 
more pronounced effect on cellular composition, specifically increasing PMN and 
macrophage percentage, compared to both CeO2 10% Gd and CeO2 20% Gd 7-day post-IT 
(Figure 2B). By 84-day post-exposure, BAL cellular composition returned to normal in 
animals exposed to pure CeO2, while CeO2 20% Gd had a persistent effect on cellular 
composition at both doses (Figure 2C).
Further, an additional set of animals were exposed to Gd2O3 nanoparticles alone to ensure 
any effects measured were due to valence state or transitional ability, rather than the 
presence of Gd in the doped nanoparticle samples. Gd2O3, at a dose equivalent to the 
amount of Gd present in the CeO2 20% Gd sample (179 µg/ kg), did not have significant 
effects on LDH or BAL cells by 84-day post-exposure (data not shown). Therefore, the 
effects caused by CeO2 20% Gd are potentially due to differences in surface reactivity, 
valence state, and oxygen vacancies, rather than the presence of Gd.
CeO2 nanoparticle effects on phagocyte activity
To determine cellular activity, a CL assay was utilized to measure ROS production. At 1-day 
post-exposure, BAL cells from all nanoparticle-treated rats at both doses significantly 
responded to zymosan stimulation compared to cells from vehicle control treated rats. Over 
time, zymosan-treated cells from exposed rats had reduced ROS production, and by 84-day 
post-exposure, ROS production was further reduced to control levels in all treatment groups 
(Figure 3A).
To determine phagocyte responsiveness and ROS production, EPR was utilized on recovered 
BAL cells. In the absence of Cr (VI) stimulus, phagocytic cells did not produce hydroxyl 
radicals (data not shown). However, following treatment with Cr (VI), phagocytic cells from 
CeO2 1 mg/kg at 7-day post-exposure produced significant levels of hydroxyl radicals 
compared to BAL cells from vehicle control-treated animals. CeO2 20% Gd significantly 
reduced the ability of the phagocytic cells to respond to Cr (VI) 84-day post-exposure 
(Figure 3B).
CeO2 nanoparticle exposure does not result in lipid peroxidation or cytokine release within 
rat lungs
CeO2 nanoparticles have previously been reported to induce inflammation and affect free 
radical production (Ma et al., 2011; Srinivas et al., 2011), and therefore, LPO end products 
and proinflammatory markers were examined. To determine downstream damage from free 
radical generation following nanoparticle exposure, MDA levels were measured in 
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pulmonary homogenates. None of the nanoparticles induced significant LPO at any of the 
time points (Figure 4). Further, IL-6, TNF-α, and IL-1β, which were measured to determine 
the pro-inflammatory potential of CeO2 nanoparticles, were not significantly elevated in 
BAL by exposure to any of the nanoparticles when compared to vehicle control animals 
(Figure 5).
CeO2 nanoparticle histopathological effects
To determine the effect of CeO2 on alveolar macrophage and granular material accumulation 
in airways, H&E staining was utilized in lung sections from animals exposed to CeO2 
nanoparticles 84-day post-exposure. All three CeO2 nanomaterials caused macrophage 
(multifocal and diffuse) accumulation in the airways and mononuclear cell infiltration in the 
alveolar septae at both 0.5 mg/kg and 1 mg/kg doses compared to PBS treated animals. Lung 
lesion severity was generally greater in CeO2 20% Gd exposed animals (Supplementary 
Figure 1, Table 2); however, there was no consistent difference in the incidence or severity 
of lung changes among the animals, making determination of the impact of valence state on 
pulmonary toxicity difficult to interpret. No significant differences were noted between 
groups at equivalent doses but there was greater severity of lung lesions in animals exposed 
to 1 mg/kg compared to those exposed at 0.5 mg/kg. All tissues from the PBS control group 
were considered within normal limits (Supplementary Figure 1, Table 2). Further, Gd2O3 
nanoparticle exposed lungs were also considered within normal limits (data not shown). To 
determine the potential for CeO2 nanomaterials to cause damage in other organs, kidney and 
liver sections were stained with H&E. No significant changes in liver or kidney were noted 
in nanoparticle exposed animals compared to PBS exposed animals (data not shown).
Discussion
As interest in CeO2 nanoparticles for industrial use increases, worker exposures will likely 
occur. The purpose of this study was to determine if altering the valence state of Ce within 
CeO2 nanoparticles by doping with Gd2O3 could mitigate its pulmonary toxicity. 
Specifically, this study assessed how changes in valence state might affect cellular influx, 
damage, and inflammation, in the lungs of rats.
As previously shown, doping substantially altered the Ce3+ / Ce4+ ratio from 16% in the 
pure CeO2 nanoparticles to 42% in the 10 mol% doped and to 44% in the 20 mol% doped 
(Dunnick et al., 2015). Doping did not affect the primary particle size but did affect 
agglomeration tendencies as increased doping was associated with increased particle 
agglomeration (Table 1). While doping significantly altered the valence state and oxygen 
vacancies between the pure and doped samples, this alteration did not dramatically affect the 
pulmonary toxicity and reactivity of CeO2 nanoparticles following IT exposures. The overall 
effect of doping on CeO2 toxicity is unclear, but it did appear that exposure to CeO2 20% Gd 
caused persistent changes (out to 84-day post-IT) in pulmonary cell counts and damage 
compared to vehicle control animals. Animals exposed to pure CeO2 or CeO2 10% Gd 
nanoparticles did not demonstrate significant increases in these parameters by the end of the 
study (Figure 2C). The difference in reactivity between the two doped samples was 
surprising due to minimal differences in Ce3+ /Ce4+ ratio between the doped nanoparticle 
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samples. However, based on our previous in vitro studies, valence state may be less 
important in modulating CeO2 nanoparticle reactivity (Dunnick et al., 2015). However, the 
content of oxygen vacancies is higher in the CeO2 20% Gd, indicating that differences in 
pulmonary toxicity may be due to changes in the redox potential of the nanomaterials. 
Therefore, the process of doping may limit the ability of nanoparticles to switch between 
valence states and increase oxygen vacancies, which may affect their reactivity in the 
pulmonary environment. A study conducted in mice also found that the pulmonary response 
to nanoparticle exposure was affected by the redox activity of CeO2 nanoparticles (Peng et 
al., 2014). Data from Peng et al. (2014) indicated that CeO2 nanoparticles with increased 
redox activity, as measured by glutathione, glutathione peroxidase, and catalase levels in 
lung homogenates, induced a mild initial pulmonary response but had more persistent long 
term effects compared to less redox active particles.
Other studies have shown that CeO2 induces inflammatory cytokine production in BAL and 
from isolated alveolar macrophages following IT (Ma et al., 2011) and inhalation (Srinivas 
et al., 2011) exposures. None of our nanoparticle samples induced the pro-inflammatory 
cytokines TNF-α, IL-6, or IL-1β over the 84-day time course, despite significant pulmonary 
PMN and macrophage influx (Figure 5). The lack of significant cytokine production 
compared to control BAL levels is likely due to differences in collection procedures, as 
cytokines from this study were measured directly from cell-free BAL rather than from the 
media of lipopolysaccharide-stimulated BAL cells (Ma et al., 2011). Additionally, 
differences in dose and exposure route may also account for a lack of inflammatory cytokine 
signaling measured in this study compared to previous in vivo CeO2 studies (Srinivas et al., 
2011). Further, it has been proposed that low cytotoxicity particles must cause excessive 
lung burden to induce pulmonary inflammation (Oberdorster, 1995); thus, at doses of 1 
mg/kg and 0.5 mg/kg, particle-overload may not have occurred or reached sufficient 
concentrations to induce inflammation as measured by cytokine production.
Ma et al. (2011)
 demonstrated that CeO2 nanoparticles severely alter AM responsiveness to 
zymosan stimulation at 1-day post-exposure; however, this response is diminished by 84-day 
post-exposure. Our data showed similar results, with BAL cells responding strongly to 
zymosan stimulation at 1-day post-exposure but minimally 84 days after exposure. 
Interestingly, our EPR results showed that BAL cells were the most responsive to Cr (VI) 
stimulation 7-day post-exposure to CeO2 nanoparticles. This may be due to a shift in the 
phagocytic cell population from mainly PMNs to a mixture of PMNs and macrophages 7-
day post-exposure (Figure 2), a trend that agrees with other nanoparticle exposure studies 
(Ma et al., 2011; Roursgaard et al., 2011). Interestingly, by 84-day post-exposure, CeO2 20% 
Gd BAL cells were significantly hindered in their ability to respond to Cr (VI) compared to 
BAL cells from control rats. This may be due to a shift in phenotypic characteristics of the 
macrophage population in the lung from day 1 to day 84. A study by Ma et al. (2011) 
described an M1 to M2 macrophage population shift following IT CeO2 exposures, while an 
in vitro silica nanoparticle exposure study showed a similar trend (Hoppstädter et al., 2015). 
Therefore, changes in macrophage population and phenotype, from residential macrophages 
originally exposed to CeO2 nanoparticles to proliferating and recruited macrophages, may 
account for the altered responsiveness to stimulus by 84-day post-exposure. A potential shift 
in macrophage populations from M2 cells, which are important in debris clearance, to M1 
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cells, which are involved in wound healing and anti-inflammatory effects (Rey-Giraud et al., 
2012), may also account for the decreased pulmonary damage observed (measured by LDH) 
over the 84-day time course. Additionally, CeO2 has been shown to transport throughout the 
body following IT instillation in rats (Nalabotu et al., 2011; Xiao et al., 2010). However, the 
lack of pathological changes measured in both liver and kidney sections indicates that by 84-
day post-exposure, translocation at toxic, measurable levels had not occurred.
Previous studies have shown that following CeO2 inhalation in CD1 mice, significant 
changes in LPO and glutathione levels occur (Aalapati et al., 2014). Therefore, we assessed 
LPO as a downstream endpoint of oxidative stress. However, in our study, none of the 
nanoparticles induced significant oxidative lung injury in lung tissue as measured by LPO 
formation (Figure 4). This is further supported by the lack of free radical production 
measured by EPR in the absence of Cr (VI) as a stimulus. These differences may be due to 
the exposure route, dose, and in vivo model system variances among studies.
Previous studies have suggested that the valence state of Ce within CeO2 affects the 
potential toxicity of the nanoparticles (Colon et al., 2010; Das et al., 2007); however, our 
findings do not indicate a direct correlation between valence state and toxicity over an 84-
day time course. This may be due to low doses that would more closely model human 
exposure levels and minimal differences in valence state between the CeO2 10% Gd and 
CeO2 20% Gd. Differences in the extent of toxicity between the two doped nanoparticles 
indicate that the transitional ability of CeO2, which is hindered by Gd doping, determines its 
reactivity, rather than valence state ratio. Therefore, further studies are necessary to 
determine the mechanisms by which doping CeO2 causes less toxicity initially and yet 
potentially induces persistent changes overtime. Further, numerous studies have reported 
that CeO2 has protective effects in vitro and in vivo against induced ROS damage (Hashem 
et al., 2015; Rubio et al., 2015; Zhang et al., 2014), and therefore an in vivo study in which 
damage is induced prior to CeO2 exposure may allow for the elucidation of differences in 
reactivity between doped and pure nanoparticles.
Conclusions
The present study aimed to determine the importance of valence state in CeO2 nanoparticle 
toxicity following IT exposure in rats by altering the 3+ /4+ valence state ratio and 
increasing oxygen vacancies through doping. While doping the nanoparticles with Gd 
significantly altered the valence state, minimal differences in pulmonary toxicity were noted 
between groups. Differences were observed by 84-day post-exposure to pure CeO2 
compounds; specifically that CeO2 20% Gd significantly increased LDH levels and induced 
persistent BAL cellular changes compared to PBS controls. This indicates that specific 
valence state (3+ vs. 4+) may be less important in CeO2 toxicity than hypothesized and that 
the ability of CeO2 to transition between valence states may be more important in 
determining nanoparticle reactivity. Overall, the toxicity of CeO2 nanoparticles at low doses 
following IT in rats was minimal by 84 days. Future studies need to be conducted to 
determine the effect of valence state on toxicity at higher CeO2 concentrations and longer 
post-exposure periods.
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Figure 1. 
Lactate dehydrogenase (LDH) levels and inflammatory cell counts in rat BAL over a time 
course of 84-day post-IT exposure. (A) LDH concentration in BAL 1-, 7-, and 84-day post-
CeO2 nanoparticle exposure. Square (CeO2), circle (CeO2 10% Gd), diamond (CeO2 20% 
Gd) symbols represent mean ± SEM (n = 6–7 rats/group). 0 mg/kg vehicle control animals 
are represented by hashed lines. *p < 0.05 compared to 0 mg/kg controls on corresponding 
day, %, p < 0.05 compared to pure CeO2 on corresponding day. Data are represented as 
mean number of cells and the symbols represent the mean number ± SEM (n = 6–7 rats/
group). (B) Total cells, (C) macrophages, (D) and PMNs in BAL. *p < 0.05 compared to 0 
mg/kg controls on corresponding day, %, p < 0.05 compared to pure CeO2 on corresponding 
day.
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Figure 2. 
Cell differentials from BAL over a time course of 84-day post-IT exposure. (A) Cells (200/
rat) from 1-day post-exposure. (B) 7-day post-exposure. (C) 84-day post-exposure. Data are 
presented as percentage of cells and the bars represent the mean percentage ± SEM (n = 6–7 
rats/group). *p < 0.05 compared to 0 mg/kg controls on corresponding day, ¥p < 0.05 
compared to pure CeO2 on corresponding day.
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Figure 3. 
Pulmonary phagocytic cell activity over a time course of 84-day post-exposure. (A) 
Response of AM from BAL over 84-day post-exposure to zymosan challenge. ROS 
production was measured via chemiluminescence. *p < 0.05 compared to 0 mg/kg controls 
on corresponding day, &p < 0.05 compared to 0.5 mg/kg dose of same nanoparticle on 
corresponding day. Data are represented as average luminescence and the bars represent the 
average ± SEM (n = 6–7 rats/group). (B) Phagocytic cell response to Cr (VI) challenge as 
measured by free radical production via EPR. BAL cells were combined with 200 mM 
DMPO, and 2 mM Cr (VI) for 3 min. Data represent fold change compared to 0 mg/kg 
animals and the bars represent the mean ± SEM (n = 6–7 rats/group). EPR settings were: 
center field, 3485 G; scan width, 100 G; time constant, 0.41s; modulation amplitude, 1 G; 
receiver gain, 1 × 104; frequency, 9.8 GHz; and power, 126.9 mW.
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Figure 4. 
Lipid peroxidation (LPO) in pulmonary homogenates measured as MDA in lung 
homogenates at 1-, 7-, and 84-day after exposure. Data are represented as fold change 
compared to 0 mg/kg animals and the bars represent the mean ± SEM (n = 6–7 rats/group). 
(A) CeO2. (B) CeO2 10% Gd. C. CeO2 20% Gd.
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Figure 5. 
Cytokine concentration in BAL over a time course of 84-day post-exposure. A 
Concentrations of (A) TNF-α, (B) IL-6, or (C) IL-1β in BAL from nanoparticle-treated rats 
were quantified.
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Table 1
Nanoparticle characteristics in PBS.
Nanoparticle
Hydrodynamic
diameter (nm) Zeta potential
CeO2 1166 ± 74 −32.1 ± 3.0
CeO2 10% Gd 2078 ± 32 −26.9 ± 4.1
CeO2 20% Gd 2436 ± 56 −23.4 ± 1.8
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